Program

View the video playlist of the conference presentations:

https://www.youtube.com/playlist?list=PL3Uw8LHDp-82BHctWd6L03uQRW-nV_fZ6

Time Topic Speaker
7:50- 8:00 AMIntroduction
Conference Co-Chairs
Ford von Reyn
Geisel School of Medicine
Kendall Hoyt
(morning moderator)
Geisel School of Medicine
Dickey Center for International Understanding
8:00 – 8:10 AMIntroduction to keynoteDuane Compton
Dean, Geisel School of Medicine
8:10 –
8:55 AM
Samuel L. Katz Memorial Lecture
COVID vaccines and the structural basis of immunogenicity
Jason McLellan
University of Texas, Austin
8:55 –
9:00 AM
Samuel Katz ’48, MED ’50 and DartmouthDavid Katz
9:00 –
9:10 AM
Samuel Katz and the measles vaccineJohn Modlin
Emeritus Professor of Pediatrics, Geisel School of Medicine

Peter Wright
Professor of Pediatrics, Geisel School of Medicine
9:10 –
9:15 AM
Welcome from Dartmouth CollegeSian Beilock
President, Dartmouth College
9:15 – 9:45 AMTB vaccines and the role of non-governmental organizationsClaire Wagner
Head of Corporate Strategy, Gates Medical Research Institute
9:45 – 10:00 AM Coffee
10:00 – 10:30 AMIndustrial innovation in vaccines in the COVID-19 pandemic and post-pandemic periodsPhilip Dormitzer
Global Head of Vaccines Research and Development, GSK
10:30 –
11:00 AM
The DarDar collaboration and HIV vaccine trials in TanzaniaPatricia Munseri
Associate Professor and Head of Infectious Disease Unit,
Muhimbili University of Health and Allied Sciences (MUHAS), Tanzania  
11:00 – 11:30 AMParameters of immunization that impact antibody, T cell durability, and efficacy against HIV and SARS-CoV-2Mark Connors 
Chief, HIV-Specific Immunity Section National Institutes of Health 
11:30 AM – 12 PMPanel discussion –
Morning speakers 
Moderators:
Lisa Adams
Peter Wright

Geisel School of Medicine
12:00 – 1:00 PMLunch 
1:00 – 1:15 PMCurrent vaccine research: Dartmouth and collaboratorsFord von Reyn
(afternoon moderator)
Professor of Medicine, Geisel School of Medicine
1:15 – 1:35 PMAdvances in understanding vaccine-induced immunity to poliovirusElizabeth Brickley
Professor of Epidemiology & Planetary Health, London School of Hygiene and Tropical Medicine       
1:35 – 1:55 PMMaternal vaccination to prevent neonatal herpes simplex virus infectionsDavid Leib
Professor and Chair of Microbiology and Immunology, Geisel School of Medicine
1:55 – 2:15 PMHow bigger data, smaller trials, and new technologies can advance vaccines for “tough” pathogensMargie Ackerman
Professor of Engineering, Thayer School of Engineering
2:15 – 2:45 PMThe role of academic vaccine institutesKathryn Edwards
Emeritus Professor of Pediatrics, Vanderbilt University School of Medicine
2:45 – 3:15 PMCoffee
3:15 – 3:45 PMThe challenges of vaccine misinformation and politicization Brendan Nyhan
Professor of Government, Dartmouth College
3:45 –
4:15 PM
From bench to clinic: the story of RSV vaccine developmentBarney Graham
Director of the David Satcher Global Health Equity Institute
Professor of Medicine and Microbiology, Biochemistry, and Immunology
Morehouse School of Medicine
4:15 – 5:00 PMPanel discussion –
Afternoon speakers 
Moderators:   
Lindsey Leininger
Amos Tuck School of Business   
Cody Meissner
Geisel School of Medicine
5:00 – 5:10 PMVision for a Dartmouth International Vaccine Institute (DIVI) Ford von Reyn
Geisel School of Medicine

Back to Home